Please select the option that best describes you:

Would you continue venetoclax indefinitely/until disease progression in patients treated with upfront venetoclax for TP53 mutated CLL?  



Answer from: Medical Oncologist at Academic Institution
Sign in or Register to read more

Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at St Lukes Cancer Care Assocs
Thank you, @Nicole 
Sign in or Register to read more